Dhilli R. Gorja

Zhengzhou, 450008, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

New phenylcyclopropane-carbohydrazide furan derivatives with potent anticancer activity and EGFR inhibitory potential.

New phenylcyclopropane-carbohydrazide furan derivatives with potent anticancer activity and EGFR inhibitory potential.

Journal: RSC advances

Published: December 13, 2025

Novel dual inhibitor for targeting PIM1 and FGFR1 kinases inhibits colorectal cancer growth in vitro and patient-derived xenografts in vivo.

Novel dual inhibitor for targeting PIM1 and FGFR1 kinases inhibits colorectal cancer growth in vitro and patient-derived xenografts in vivo.

Journal: Acta pharmaceutica Sinica. B

Published: March 26, 2022

Discovery of a novel dual-target inhibitor against RSK1 and MSK2 to suppress growth of human colon cancer.

Discovery of a novel dual-target inhibitor against RSK1 and MSK2 to suppress growth of human colon cancer.

Journal: Oncogene

Published: April 26, 2020

Aurora B kinase as a novel molecular target for inhibition the growth of osteosarcoma.

Aurora B kinase as a novel molecular target for inhibition the growth of osteosarcoma.

Journal: Molecular carcinogenesis

Published: November 20, 2018

APIO-EE-9 is a novel Aurora A and B antagonist that suppresses esophageal cancer growth in a PDX mouse model.

APIO-EE-9 is a novel Aurora A and B antagonist that suppresses esophageal cancer growth in a PDX mouse model.

Journal: Oncotarget

Published: November 17, 2016

The solution structure of human calcium-bound S100A4 mutated at four cysteine loci.

The solution structure of human calcium-bound S100A4 mutated at four cysteine loci.

Journal: Journal of biomolecular NMR

Published: March 02, 2015

Novel N-indolylmethyl substituted olanzapine derivatives: their design, synthesis and evaluation as PDE4B inhibitors.

Novel N-indolylmethyl substituted olanzapine derivatives: their design, synthesis and evaluation as PDE4B inhibitors.

Journal: Organic & biomolecular chemistry

Published: February 26, 2013

C-C bond formation at C-2 of a quinoline ring: synthesis of 2-(1H-indol-3-yl)quinoline-3-carbonitrile derivatives as a new class of PDE4 inhibitors.

C-C bond formation at C-2 of a quinoline ring: synthesis of 2-(1H-indol-3-yl)quinoline-3-carbonitrile derivatives as a new class of PDE4 inhibitors.

Journal: Bioorganic & medicinal chemistry

Published: January 18, 2012

Design and synthesis of 4-alkynyl pyrazoles as inhibitors of PDE4: a practical access via Pd/C-Cu catalysis.

Design and synthesis of 4-alkynyl pyrazoles as inhibitors of PDE4: a practical access via Pd/C-Cu catalysis.

Journal: Bioorganic & medicinal chemistry letters

Published: November 25, 2011

Showing 1-9 of 9

Last Updated: 09/26/2026